Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas

The Cancer Genome Atlas Research Network

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

DNA damage repair (DDR) pathways modulate cancer risk, progression, and therapeutic response. We systematically analyzed somatic alterations to provide a comprehensive view of DDR deficiency across 33 cancer types. Mutations with accompanying loss of heterozygosity were observed in over 1/3 of DDR genes, including TP53 and BRCA1/2. Other prevalent alterations included epigenetic silencing of the direct repair genes EXO5, MGMT, and ALKBH3 in ∼20% of samples. Homologous recombination deficiency (HRD) was present at varying frequency in many cancer types, most notably ovarian cancer. However, in contrast to ovarian cancer, HRD was associated with worse outcomes in several other cancers. Protein structure-based analyses allowed us to predict functional consequences of rare, recurrent DDR mutations. A new machine-learning-based classifier developed from gene expression data allowed us to identify alterations that phenocopy deleterious TP53 mutations. These frequent DDR gene alterations in many human cancers have functional consequences that may determine cancer progression and guide therapy. Knijnenburg et al. present The Cancer Genome Atlas (TCGA) Pan-Cancer analysis of DNA damage repair (DDR) deficiency in cancer. They use integrative genomic and molecular analyses to identify frequent DDR alterations across 33 cancer types, correlate gene- and pathway-level alterations with genome-wide measures of genome instability and impaired function, and demonstrate the prognostic utility of DDR deficiency scores.

Original languageEnglish (US)
Pages (from-to)239-254.e6
JournalCell Reports
Volume23
Issue number1
DOIs
StatePublished - Apr 3 2018

Fingerprint

DNA Repair-Deficiency Disorders
Atlases
DNA Damage
Repair
Genes
Genome
DNA
DNA Repair
Neoplasms
Homologous Recombination
Ovarian Neoplasms
Mutation
BRCA1 Gene
Genomic Instability
Loss of Heterozygosity
Neoplasm Genes
p53 Genes
Epigenomics
Gene expression
Learning systems

Keywords

  • DNA damage footprints
  • DNA damage repair
  • The Cancer Genome Atlas PanCanAtlas project
  • epigenetic silencing
  • integrative statistical analysis
  • mutational signatures
  • protein structure analysis
  • somatic copy-number alterations
  • somatic mutations

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas. / The Cancer Genome Atlas Research Network.

In: Cell Reports, Vol. 23, No. 1, 03.04.2018, p. 239-254.e6.

Research output: Contribution to journalArticle

The Cancer Genome Atlas Research Network. / Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas. In: Cell Reports. 2018 ; Vol. 23, No. 1. pp. 239-254.e6.
@article{a39e33bf63804372b1d5d74812bf0538,
title = "Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas",
abstract = "DNA damage repair (DDR) pathways modulate cancer risk, progression, and therapeutic response. We systematically analyzed somatic alterations to provide a comprehensive view of DDR deficiency across 33 cancer types. Mutations with accompanying loss of heterozygosity were observed in over 1/3 of DDR genes, including TP53 and BRCA1/2. Other prevalent alterations included epigenetic silencing of the direct repair genes EXO5, MGMT, and ALKBH3 in ∼20{\%} of samples. Homologous recombination deficiency (HRD) was present at varying frequency in many cancer types, most notably ovarian cancer. However, in contrast to ovarian cancer, HRD was associated with worse outcomes in several other cancers. Protein structure-based analyses allowed us to predict functional consequences of rare, recurrent DDR mutations. A new machine-learning-based classifier developed from gene expression data allowed us to identify alterations that phenocopy deleterious TP53 mutations. These frequent DDR gene alterations in many human cancers have functional consequences that may determine cancer progression and guide therapy. Knijnenburg et al. present The Cancer Genome Atlas (TCGA) Pan-Cancer analysis of DNA damage repair (DDR) deficiency in cancer. They use integrative genomic and molecular analyses to identify frequent DDR alterations across 33 cancer types, correlate gene- and pathway-level alterations with genome-wide measures of genome instability and impaired function, and demonstrate the prognostic utility of DDR deficiency scores.",
keywords = "DNA damage footprints, DNA damage repair, The Cancer Genome Atlas PanCanAtlas project, epigenetic silencing, integrative statistical analysis, mutational signatures, protein structure analysis, somatic copy-number alterations, somatic mutations",
author = "{The Cancer Genome Atlas Research Network} and Knijnenburg, {Theo A.} and Linghua Wang and Zimmermann, {Michael T.} and Nyasha Chambwe and Gao, {Galen F.} and Cherniack, {Andrew D.} and Huihui Fan and Hui Shen and Way, {Gregory P.} and Greene, {Casey S.} and Yuexin Liu and Rehan Akbani and Bin Feng and Donehower, {Lawrence A.} and Chase Miller and Yang Shen and Mostafa Karimi and Haoran Chen and Pora Kim and Peilin Jia and Eve Shinbrot and Shaojun Zhang and Jianfang Liu and Hai Hu and Bailey, {Matthew H.} and Christina Yau and Denise Wolf and Zhongming Zhao and Weinstein, {John N.} and Lei Li and Li Ding and Mills, {Gordon B.} and Laird, {Peter W.} and Wheeler, {David A.} and Ilya Shmulevich and Caesar-Johnson, {Samantha J.} and Demchok, {John A.} and Ina Felau and Melpomeni Kasapi and Ferguson, {Martin L.} and Hutter, {Carolyn M.} and Sofia, {Heidi J.} and Roy Tarnuzzer and Zhining Wang and Liming Yang and Zenklusen, {Jean C.} and Zhang, {Jiashan (Julia)} and Sudha Chudamani and Laxmi Lolla and Zaren, {Howard A.}",
year = "2018",
month = "4",
day = "3",
doi = "10.1016/j.celrep.2018.03.076",
language = "English (US)",
volume = "23",
pages = "239--254.e6",
journal = "Cell Reports",
issn = "2211-1247",
publisher = "Cell Press",
number = "1",

}

TY - JOUR

T1 - Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas

AU - The Cancer Genome Atlas Research Network

AU - Knijnenburg, Theo A.

AU - Wang, Linghua

AU - Zimmermann, Michael T.

AU - Chambwe, Nyasha

AU - Gao, Galen F.

AU - Cherniack, Andrew D.

AU - Fan, Huihui

AU - Shen, Hui

AU - Way, Gregory P.

AU - Greene, Casey S.

AU - Liu, Yuexin

AU - Akbani, Rehan

AU - Feng, Bin

AU - Donehower, Lawrence A.

AU - Miller, Chase

AU - Shen, Yang

AU - Karimi, Mostafa

AU - Chen, Haoran

AU - Kim, Pora

AU - Jia, Peilin

AU - Shinbrot, Eve

AU - Zhang, Shaojun

AU - Liu, Jianfang

AU - Hu, Hai

AU - Bailey, Matthew H.

AU - Yau, Christina

AU - Wolf, Denise

AU - Zhao, Zhongming

AU - Weinstein, John N.

AU - Li, Lei

AU - Ding, Li

AU - Mills, Gordon B.

AU - Laird, Peter W.

AU - Wheeler, David A.

AU - Shmulevich, Ilya

AU - Caesar-Johnson, Samantha J.

AU - Demchok, John A.

AU - Felau, Ina

AU - Kasapi, Melpomeni

AU - Ferguson, Martin L.

AU - Hutter, Carolyn M.

AU - Sofia, Heidi J.

AU - Tarnuzzer, Roy

AU - Wang, Zhining

AU - Yang, Liming

AU - Zenklusen, Jean C.

AU - Zhang, Jiashan (Julia)

AU - Chudamani, Sudha

AU - Lolla, Laxmi

AU - Zaren, Howard A.

PY - 2018/4/3

Y1 - 2018/4/3

N2 - DNA damage repair (DDR) pathways modulate cancer risk, progression, and therapeutic response. We systematically analyzed somatic alterations to provide a comprehensive view of DDR deficiency across 33 cancer types. Mutations with accompanying loss of heterozygosity were observed in over 1/3 of DDR genes, including TP53 and BRCA1/2. Other prevalent alterations included epigenetic silencing of the direct repair genes EXO5, MGMT, and ALKBH3 in ∼20% of samples. Homologous recombination deficiency (HRD) was present at varying frequency in many cancer types, most notably ovarian cancer. However, in contrast to ovarian cancer, HRD was associated with worse outcomes in several other cancers. Protein structure-based analyses allowed us to predict functional consequences of rare, recurrent DDR mutations. A new machine-learning-based classifier developed from gene expression data allowed us to identify alterations that phenocopy deleterious TP53 mutations. These frequent DDR gene alterations in many human cancers have functional consequences that may determine cancer progression and guide therapy. Knijnenburg et al. present The Cancer Genome Atlas (TCGA) Pan-Cancer analysis of DNA damage repair (DDR) deficiency in cancer. They use integrative genomic and molecular analyses to identify frequent DDR alterations across 33 cancer types, correlate gene- and pathway-level alterations with genome-wide measures of genome instability and impaired function, and demonstrate the prognostic utility of DDR deficiency scores.

AB - DNA damage repair (DDR) pathways modulate cancer risk, progression, and therapeutic response. We systematically analyzed somatic alterations to provide a comprehensive view of DDR deficiency across 33 cancer types. Mutations with accompanying loss of heterozygosity were observed in over 1/3 of DDR genes, including TP53 and BRCA1/2. Other prevalent alterations included epigenetic silencing of the direct repair genes EXO5, MGMT, and ALKBH3 in ∼20% of samples. Homologous recombination deficiency (HRD) was present at varying frequency in many cancer types, most notably ovarian cancer. However, in contrast to ovarian cancer, HRD was associated with worse outcomes in several other cancers. Protein structure-based analyses allowed us to predict functional consequences of rare, recurrent DDR mutations. A new machine-learning-based classifier developed from gene expression data allowed us to identify alterations that phenocopy deleterious TP53 mutations. These frequent DDR gene alterations in many human cancers have functional consequences that may determine cancer progression and guide therapy. Knijnenburg et al. present The Cancer Genome Atlas (TCGA) Pan-Cancer analysis of DNA damage repair (DDR) deficiency in cancer. They use integrative genomic and molecular analyses to identify frequent DDR alterations across 33 cancer types, correlate gene- and pathway-level alterations with genome-wide measures of genome instability and impaired function, and demonstrate the prognostic utility of DDR deficiency scores.

KW - DNA damage footprints

KW - DNA damage repair

KW - The Cancer Genome Atlas PanCanAtlas project

KW - epigenetic silencing

KW - integrative statistical analysis

KW - mutational signatures

KW - protein structure analysis

KW - somatic copy-number alterations

KW - somatic mutations

UR - http://www.scopus.com/inward/record.url?scp=85044676615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044676615&partnerID=8YFLogxK

U2 - 10.1016/j.celrep.2018.03.076

DO - 10.1016/j.celrep.2018.03.076

M3 - Article

VL - 23

SP - 239-254.e6

JO - Cell Reports

JF - Cell Reports

SN - 2211-1247

IS - 1

ER -